ConductScience.org, home

Paper35106919

Patterns of the use of advanced radiation therapy techniques for the management of bone metastases and the associated factors in Victoria.

Fogarty T and 8 others. J Med Imaging Radiat Oncol, 2022. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Patterns of the use of advanced radiation therapy techniques for the management of bone metastases and the associated factors in Victoria. Papers, record 35106919. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35106919

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Patterns of the use of advanced radiation therapy techniques for the management of bone metastases and the associated factors in Victoria.
PubMed
Journal
J Med Imaging Radiat Oncol
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.71
iCite
Revised in PubMed
2025-07-28
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fogarty TTamarahttps://orcid.org/0000-0002-3383-4656
2Tacey MMark
3McCorkell GGiulia
4Kok DDavid
5Hornby CColin
6Milne RLRoger L
7Millar JJeremy
8Foroudi FFarshadhttps://orcid.org/0000-0001-8387-0965
9Ong WLWee Loonhttps://orcid.org/0000-0001-6657-7193

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
RadiosurgeryMajor topic
Radiotherapy, Intensity-ModulatedMajor topic
Spinal NeoplasmsMajor topic
Aged
Humans
Male
Medicare
Radiotherapy Dosage
Radiotherapy Planning, Computer-Assisted
United States

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Council of Australian University LibrariansPubMed
Monash UniversityPubMed

Source PubMed

Download CSV of grants

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131734589Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: A prospective clinical trial.Breast2020https://conductscience.org/library/papers/31734589PubMed
230061275
Quality of Life and Radiation-induced Late Toxicity Following Intensity-modulated Versus Three-dimensional Conformal Radiotherapy for Patients with Spinal Bone Metastases: Results of a Randomized Trial.
Anticancer Res2018https://conductscience.org/library/papers/30061275PubMed
333217497Patterns of use of palliative radiotherapy fractionation for bone metastases and 30-day mortality.Radiother Oncol2021https://conductscience.org/library/papers/33217497PubMed
417416863Palliative radiotherapy trials for bone metastases: a systematic review.J Clin Oncol2007https://conductscience.org/library/papers/17416863PubMed
532114269Single fraction radiosurgery, fractionated radiosurgery, and conventional radiotherapy for spinal oligometastasis (SAFFRON): A systematic review and meta-analysis.Radiother Oncol2020https://conductscience.org/library/papers/32114269PubMed
629843899Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy.Radiother Oncol2018https://conductscience.org/library/papers/29843899PubMed
731505246Variation in the Use of Single- Versus Multifraction Palliative Radiation Therapy for Bone Metastases in Australia.Int J Radiat Oncol Biol Phys2020https://conductscience.org/library/papers/31505246PubMed
830227924Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial.Eur Urol2018https://conductscience.org/library/papers/30227924PubMed
922673744Intensity-modulated radiotherapy in the treatment of prostate cancer.Clin Oncol (R Coll Radiol)2012https://conductscience.org/library/papers/22673744PubMed
1029978307
Radiation-induced acute toxicities after image-guided intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for patients with spinal metastases (IRON-1 trial) : First results of a randomized controlled trial.
Strahlenther Onkol2018https://conductscience.org/library/papers/29978307PubMed
1130849005Trends in Radiation for Bone Metastasis During a Period of Multiple National Quality Improvement Initiatives.J Oncol Pract2019https://conductscience.org/library/papers/30849005PubMed
1225345713Trans Tasman Radiation Oncology Group: Development of the Assessment of New Radiation Oncology Technology and Treatments (ANROTAT) Framework.J Med Imaging Radiat Oncol2015https://conductscience.org/library/papers/25345713PubMed
1326229674Dose planning objectives in anal canal cancer IMRT: the TROG ANROTAT experience.J Med Radiat Sci2015https://conductscience.org/library/papers/26229674PubMed
1426439588Testing the Assessment of New Radiation Oncology Technology and Treatments framework using the evaluation of post-prostatectomy radiotherapy techniques.J Med Imaging Radiat Oncol2016https://conductscience.org/library/papers/26439588PubMed
1531021390Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 Trial.JAMA Oncol2019https://conductscience.org/library/papers/31021390PubMed
1633333200Pain Response After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases-A Phase 2 Randomized Controlled Trial Within a Prospective Cohort.Int J Radiat Oncol Biol Phys2021https://conductscience.org/library/papers/33333200PubMed
1730770291Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.Lancet Oncol2019https://conductscience.org/library/papers/30770291PubMed
1833309977Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of the SABR-COMET Randomized Trial.Int J Radiat Oncol Biol Phys2021https://conductscience.org/library/papers/33309977PubMed
1934126044Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial.Lancet Oncol2021https://conductscience.org/library/papers/34126044PubMed
2032584700Advanced Radiation Therapy Technology Use in the Treatment of Bone Metastases in a Public, Salary-Funded, Non-Incentivized Health Care System.JCO Oncol Pract2021https://conductscience.org/library/papers/32584700PubMed

See all 22 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
37623045Stereotactic Body Radiation Therapy for Spine Metastases-Findings from an Australian Population-Based Study.Curr Oncol2023https://conductscience.org/library/papers/37623045PubMed
35599450Large variation in radiation therapy fractionation for multiple myeloma in Australia.Asia Pac J Clin Oncol2023https://conductscience.org/library/papers/35599450PubMed
35323367Evaluation of Patient-Reported Outcome Differences by Radiotherapy Techniques for Bone Metastases in A Population-Based Healthcare System.Curr Oncol2022https://conductscience.org/library/papers/35323367PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35106919

GET https://conductscience.org/api/papers/v1/35106919/references?page=2